Market research

Animal Gut Health Products Market

Explore licenses

Assess the study’s coverageRead the public overview, then compare the chapter outline with your research brief.

17report chapters

360iResearch introduction

Public research overview

Animal Gut Health Products: Executive Summary

Animal gut health products encompass nutritional, microbial, and feed-based interventions designed to support digestive function, intestinal integrity, immune response, and production resilience in livestock, poultry, aquaculture, and companion animals. The category includes probiotics, prebiotics, postbiotics, organic acids, enzymes, phytogenic compounds, and related formulation and delivery systems. Demand is shaped by antimicrobial stewardship, disease prevention, feed efficiency, animal welfare, and the need for more consistent performance under changing husbandry conditions.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to see every subchapter in context.

  1. Chapter 7 Product Type

    • Enzymes
    • Organic Acids
    • Phytogenics
    • Prebiotics
    More in this chapter
  2. Chapter 8 Animal Type

    • Aquaculture
    • Companion Animals
    • Poultry
    • Ruminants
    More in this chapter
  3. Chapter 9 Form

    • Dry
    • Gel
    • Liquid
    View chapter

From Routine Supplementation to Preventive Herd Management

The landscape is shifting from routine supplementation toward integrated gut-health programs that combine feed formulation, farm hygiene, vaccination, diagnostics, water management, and continuous monitoring. Producers increasingly evaluate products by functional outcomes-such as feed conversion, mortality reduction, pathogen control, and uniformity-rather than by ingredient category alone. Regulatory scrutiny of antimicrobial use, tighter residue expectations, and sustainability objectives are also encouraging non-antibiotic approaches, while formulation stability, evidence quality, and ease of on-farm application remain decisive adoption factors.

Artificial Intelligence Strengthens Diagnosis, Formulation, and Traceability

Artificial intelligence is contributing to gut-health management by combining animal performance records, feed data, environmental readings, microbiome information, and veterinary observations. These tools can help identify deviations earlier, segment animals by risk, optimize additive combinations, and support targeted interventions. Computer vision and sensor systems may improve detection of feeding, behavior, or welfare changes, while machine-learning workflows can assist quality control and traceability. Adoption remains dependent on reliable datasets, interoperable farm systems, transparent validation, cybersecurity, and clear accountability for veterinary decisions.

Regional Insights: Regulation and Production Systems Shape Adoption

North America emphasizes evidence-based functional claims, antimicrobial stewardship, and integration with intensive livestock and poultry operations. Latin America is influenced by export requirements, poultry and swine productivity, climate variability, and uneven access to technical support. Europe places strong emphasis on animal welfare, feed safety, environmental performance, and regulatory substantiation. The Middle East is shaped by heat stress, water constraints, imported feed inputs, and the need for resilient production systems. Africa presents diverse conditions, including smallholder participation, disease pressure, infrastructure gaps, and growing commercial production. Asia-Pacific combines large and varied animal-production systems with strong interest in disease prevention, aquaculture, feed efficiency, and scalable delivery formats.

Group Insights: Trade Rules and Policy Alignment Influence Market Access

ASEAN adoption reflects diverse regulatory systems, tropical production conditions, aquaculture activity, and the importance of practical formulations for fragmented supply chains. BRICS economies combine large domestic production bases with differing standards, research capacity, and biosecurity priorities. The European Union maintains a highly structured environment for feed additives, welfare, sustainability, and scientific substantiation. G7 countries generally emphasize advanced diagnostics, traceability, antimicrobial stewardship, and high-quality evidence. GCC members face heat, water, and feed-security challenges that increase interest in resilience-oriented nutrition. NATO members span varied production systems but share strategic attention to food-system resilience, supply continuity, and biosecurity.

Country Insights: Diverse Priorities Across Major Production Markets

Australia prioritizes extensive-production resilience, pasture systems, and heat and drought management. Brazil focuses on poultry, swine, cattle, export compliance, and scalable feed applications. Canada emphasizes cold-climate production, feed safety, and antimicrobial stewardship. China combines large-scale livestock and aquaculture systems with strong interest in disease prevention and production efficiency. France, Germany, Italy, and Spain operate within stringent European requirements while addressing welfare, sustainability, and species-specific productivity needs. India’s priorities include affordability, poultry and dairy productivity, and variable farm infrastructure. Japan and South Korea emphasize precision production, food safety, and advanced husbandry. Mexico is shaped by poultry, swine, export-linked standards, and climate pressures. Russia faces supply-chain, climate, and domestic production considerations. The United Kingdom emphasizes post-EU regulatory implementation, welfare, traceability, and responsible antimicrobial use. The United States combines intensive production, veterinary oversight, feed innovation, and data-enabled management.

Action Priorities for Industry Leaders

Leaders should build product portfolios around validated functional outcomes and species-specific use cases rather than broad wellness claims. They should generate reproducible evidence across commercial farms, disclose mechanisms and limitations, and align dossiers with local regulatory requirements. Partnerships with veterinarians, nutritionists, integrators, laboratories, and technology providers can improve deployment and measurement. Companies should also invest in formulation stability, supply-chain redundancy, quality assurance, and practical dosing formats. Finally, integrating products with diagnostics and farm-management platforms can support outcome tracking while maintaining data governance, operator training, and responsible use of artificial intelligence.

Research Methodology: Evidence-Based Market Assessment

The assessment uses a structured review of publicly available regulatory materials, scientific and veterinary literature, production-system research, antimicrobial-stewardship guidance, trade and food-safety documentation, and regional industry practices. Findings are organized by product function, animal species, application route, geography, policy environment, and adoption barrier. Cross-checking emphasizes source consistency, distinction between demonstrated outcomes and commercial claims, and recognition of differences among intensive, extensive, smallholder, and aquaculture systems. Artificial-intelligence observations are treated as emerging applications and are separated from established operational practices.

Conclusion: Gut Health Becomes a Core Production Capability

Animal gut health products are increasingly positioned as part of preventive, data-informed production management rather than as standalone feed supplements. The strongest opportunities are associated with credible evidence, regulatory fit, operational simplicity, and measurable improvements in animal resilience and resource efficiency. Regional and country conditions require localized formulations, claims, partnerships, and implementation models. Industry leaders that connect gut-health interventions with diagnostics, biosecurity, welfare, and responsible data use will be better placed to support durable outcomes across diverse animal-production systems.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Animal Gut Health Products Market, by Product Type
    1. 7.1Introduction
    2. 7.2Enzymes
    3. 7.3Organic Acids
    4. 7.4Phytogenics
    5. 7.5Prebiotics
    6. 7.6Probiotics
  8. 8.Animal Gut Health Products Market, by Animal Type
    1. 8.1Introduction
    2. 8.2Aquaculture
      1. 8.2.1Fish
      2. 8.2.2Shrimp
    3. 8.3Companion Animals
      1. 8.3.1Cats
      2. 8.3.2Dogs
    4. 8.4Poultry
      1. 8.4.1Broilers
      2. 8.4.2Layers
    5. 8.5Ruminants
      1. 8.5.1Beef Cattle
      2. 8.5.2Dairy Cattle
    6. 8.6Swine
      1. 8.6.1Grower Finisher
      2. 8.6.2Sows
      3. 8.6.3Weaner
  9. 9.Animal Gut Health Products Market, by Form
    1. 9.1Introduction
    2. 9.2Dry
    3. 9.3Gel
    4. 9.4Liquid
  10. 10.Animal Gut Health Products Market, by Application
    1. 10.1Introduction
    2. 10.2Disease Prevention
    3. 10.3Performance Enhancement
    4. 10.4Therapeutic Support
  11. 11.Animal Gut Health Products Market, by Sales Channel
    1. 11.1Introduction
    2. 11.2Online
    3. 11.3Offline
  12. 12.Animal Gut Health Products Market, by Region
    1. 12.1Introduction
    2. 12.2Asia-Pacific
    3. 12.3North America
    4. 12.4Latin America
    5. 12.5Europe
    6. 12.6Middle East
    7. 12.7Africa
  13. 13.Animal Gut Health Products Market, by Group
    1. 13.1Introduction
    2. 13.2ASEAN
    3. 13.3GCC
    4. 13.4European Union
    5. 13.5BRICS
    6. 13.6G7
    7. 13.7NATO
  14. 14.Animal Gut Health Products Market, by Country
    1. 14.1Introduction
    2. 14.2United States
    3. 14.3Canada
    4. 14.4Mexico
    5. 14.5Brazil
    6. 14.6United Kingdom
    7. 14.7Germany
    8. 14.8France
    9. 14.9Russia
    10. 14.10Italy
    11. 14.11Spain
    12. 14.12China
    13. 14.13India
    14. 14.14Japan
    15. 14.15Australia
    16. 14.16South Korea
  15. 15.Competitive Landscape
    1. 15.1Market Share Analysis, 2025
    2. 15.2Market Concentration Analysis, 2025
      1. 15.2.1Concentration Ratio (CR)
      2. 15.2.2Herfindahl Hirschman Index (HHI)
    3. 15.3Recent Developments & Impact Analysis, 2025
    4. 15.4Product Portfolio Analysis, 2025
    5. 15.5Benchmarking Analysis, 2025
  16. 16.Company Profiles
    1. 16.1ADM Animal Nutrition
    2. 16.2Alembic Animal Health
    3. 16.3Alltech, Inc.
    4. 16.4ATN Biopharma Pvt. Ltd.
    5. 16.5Boehringer Ingelheim Animal Health GmbH
    6. 16.6Cargill, Incorporated
    7. 16.7Dechra Pharmaceuticals PLC
    8. 16.8Elanco Animal Health Incorporated
    9. 16.9Growel Agrovet Pvt. Ltd.
    10. 16.10Hester Biosciences Limited
    11. 16.11Indian Immunologicals Limited
    12. 16.12Inmed Animal Health Pvt. Ltd.
    13. 16.13Intas Animal Health
    14. 16.14Kemin Industries, Inc.
    15. 16.15Merck Animal Health
    16. 16.16Novus International, Inc.
    17. 16.17Nutreco N.V.
    18. 16.18Phibro Animal Health Corporation
    19. 16.19SeQuent Scientific Limited
    20. 16.20Vetnation Pharma Pvt. Ltd.
    21. 16.21Vetoquinol S.A.
    22. 16.22Zoetis Inc.
  17. 17.Key Experts

Loading the sample request form…